Study finds exercise decreases among people taking GLP-1 medication

MedicalXpress | 六月 13, 2026

Adults with obesity who lost weight with glucagon-like peptide-1 (GLP-1) receptor agonist medications significantly decreased their physical activity, which is essential to protect muscle, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago.